Trademark: IMMUNITYBIO 2371072
Word
IMMUNITYBIO
ID
2371072
Trademark Type
Word
Status
Protected: Registered/protected
Application Date
01 March 2023
Registration Date
01 March 2023
Renewal Date
01 March 2033
Owner(s)
Service
Goods and Services:
Class 5:
Pharmaceutical preparations and substances for the treatment of human diseases, animal diseases, autoimmune diseases, infectious diseases and cancer for scientific, clinical, medicinal, therapeutic, and diagnostic purposes; pharmaceutical preparations and substances for the prevention, diagnosis, and treatment of human diseases, animal diseases, autoimmune diseases, infectious diseases and cancer; pharmaceutical and biological preparations for use in targeted immunotherapy for the treatment of human diseases, animal diseases, autoimmune diseases, infectious diseases and cancer; biological preparations for medical purposes, namely, in the field of vaccines; pharmaceutical preparations for low-dose chemotherapies, low dose radiation therapies, and personalized neoepitope-targeted therapies for medical use for the treatment of human diseases, animal diseases, autoimmune diseases, infectious diseases, and cancer; anti-cancer preparations; vaccines; biologics, namely, cell-derived preparations, pharmaceutical preparations for cell therapies, monoclonal antibodies, cytokines, immune modulators, pharmaceutical preparations for low-dose chemotherapy and low-dose radiation therapy, antibodies, fusion proteins, peptide and cytokine biologics, vaccines, pharmaceutical preparations for personalized neoepitope-based therapies and cell therapies, and natural killer cell derived preparations for clinical, medicinal, therapeutic, and veterinary purposes; kits for clinical, medicinal, therapeutic, and veterinary purposes featuring cell cultures, and reagents.
Pharmaceutical preparations and substances for the treatment of human diseases, animal diseases, autoimmune diseases, infectious diseases and cancer for scientific, clinical, medicinal, therapeutic, and diagnostic purposes; pharmaceutical preparations and substances for the prevention, diagnosis, and treatment of human diseases, animal diseases, autoimmune diseases, infectious diseases and cancer; pharmaceutical and biological preparations for use in targeted immunotherapy for the treatment of human diseases, animal diseases, autoimmune diseases, infectious diseases and cancer; biological preparations for medical purposes, namely, in the field of vaccines; pharmaceutical preparations for low-dose chemotherapies, low dose radiation therapies, and personalized neoepitope-targeted therapies for medical use for the treatment of human diseases, animal diseases, autoimmune diseases, infectious diseases, and cancer; anti-cancer preparations; vaccines; biologics, namely, cell-derived preparations, pharmaceutical preparations for cell therapies, monoclonal antibodies, cytokines, immune modulators, pharmaceutical preparations for low-dose chemotherapy and low-dose radiation therapy, antibodies, fusion proteins, peptide and cytokine biologics, vaccines, pharmaceutical preparations for personalized neoepitope-based therapies and cell therapies, and natural killer cell derived preparations for clinical, medicinal, therapeutic, and veterinary purposes; kits for clinical, medicinal, therapeutic, and veterinary purposes featuring cell cultures, and reagents.
Class 42:
Medical and pharmaceutical research and development services; medical and scientific research in the fields of pharmaceuticals, oncology, immune-oncology, immunotherapy, human diseases, animal diseases, cancer, vaccines, autoimmune diseases, and infectious diseases; product development in the fields of pharmaceuticals, oncology, immune-oncology, immunotherapy, human diseases, animal diseases, cancer, vaccines, autoimmune diseases, and infectious diseases.
Medical and pharmaceutical research and development services; medical and scientific research in the fields of pharmaceuticals, oncology, immune-oncology, immunotherapy, human diseases, animal diseases, cancer, vaccines, autoimmune diseases, and infectious diseases; product development in the fields of pharmaceuticals, oncology, immune-oncology, immunotherapy, human diseases, animal diseases, cancer, vaccines, autoimmune diseases, and infectious diseases.
Class 44:
Medical services; medical information; providing medical information in the fields of immunotherapy via a website; providing medical information in the fields of human diseases, animal diseases, cancer, vaccines, autoimmune diseases, and infectious diseases via a website; providing information relating to pharmaceuticals, oncology, immune-oncology, immunotherapy, human diseases, animal diseases, cancer, vaccines, autoimmune diseases, infectious diseases, biologics, cells, and cell-derived preparations.
Medical services; medical information; providing medical information in the fields of immunotherapy via a website; providing medical information in the fields of human diseases, animal diseases, cancer, vaccines, autoimmune diseases, and infectious diseases via a website; providing information relating to pharmaceuticals, oncology, immune-oncology, immunotherapy, human diseases, animal diseases, cancer, vaccines, autoimmune diseases, infectious diseases, biologics, cells, and cell-derived preparations.